Quest Diagnostics Incorporated Stock Pattern Recognition Piercing Pattern
| DGX Stock | USD 201.46 0.00 0.00% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The Piercing pattern may indicate Quest Diagnostics low bullish reversal trend.
Quest Diagnostics Technical Analysis Modules
Most technical analysis of Quest Diagnostics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Quest from various momentum indicators to cycle indicators. When you analyze Quest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
How Much Is Quest Diagnostics Worth?
Quest Diagnostics is a large-cap equity in Health Care Providers & Services, Health Care Equipment & Services, Health Care categories. Intrinsic value assumptions are benchmarked against sector averages. This analysis reviews how Quest Diagnostics integrates into a multi-asset portfolio across market cycles.
Methodology
Unless otherwise specified, financial data for Quest Diagnostics Incorporated is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Quest (USA Stocks:DGX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
The dataset for Quest Diagnostics Incorporated incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Quest Diagnostics Incorporated is covered by 17 analysts. 8 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, BMO Capital Markets, HSBC Global Research, Jefferies, among others. Updates may occur throughout the day.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Quest Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Quest Diagnostics' short interest history, or implied volatility extrapolated from Quest Diagnostics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 20 shares | |
 | Plastics Invested over 60 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Macroaxis Picks Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Advertising Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | FinTech Invested over 20 shares | |
 | Chemicals Makers Invested over 70 shares | |
 | Macroaxis Index Invested over 60 shares | |
More Resources for Quest Stock Analysis
A structured review of Quest Diagnostics often starts with core financial statements and trend context. Ratios and trend metrics help frame Quest Diagnostics' operating context. Key reports that frame Quest Diagnostics Incorporated Stock are listed below:Use Investing Opportunities to better understand diversified portfolio construction. Clearer exposure analysis supports long-term portfolio balance. This includes a position in Quest Diagnostics Incorporated in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. Analysis related to Quest Diagnostics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Quarterly Earnings Growth 0.11 | Dividend Share 3.2 | Earnings Share 8.75 | Revenue Per Share | Quarterly Revenue Growth 0.071 |
The market value of Quest Diagnostics is measured differently than book value, which reflects Quest accounting equity. Intrinsic value is an analytical estimate of Quest Diagnostics' underlying worth that can differ from price and book value. Prices respond to market conditions and behavior, which can widen gaps versus fundamentals. Valuation methods help interpret those gaps.
Note that Quest Diagnostics' intrinsic value and market price are different measures derived from different inputs. A full view may include fundamental ratios, momentum patterns, industry dynamics, and analyst estimates. Market price reflects the current exchange level formed by active bids and offers.